European Journal of Internal Medicine
Volume 19, Issue 3 , Pages 192-197, May 2008

Clinical outcome in patients with peripheral artery disease. Results from a prospective registry (FRENA)

  • Manuel Monreal

      Affiliations

    • Servicio de Medicina Interna. Hospital Universitari Germans Trias i Pujol, Badalona, Spain
    • Corresponding Author InformationCorresponding author. Servicio de Medicina Interna. Hospital Universitari Germans Trias i Pujol. 08916 Badalona (Barcelona). Spain. Tel.: +34 669675313.
  • ,
  • Lorenzo Alvarez

      Affiliations

    • Servicio de Angiología y Cirugía Vascular. Hospital Universitari Germans Trias i Pujol, Badalona, Spain
  • ,
  • Blanca Vilaseca

      Affiliations

    • Servicio de Medicina Interna. Hospital Universitari Germans Trias i Pujol, Badalona, Spain
  • ,
  • Ramón Coll

      Affiliations

    • Servicio de Rehabilitación. Hospital Universitari Germans Trias i Pujol, Badalona, Spain
  • ,
  • Carmen Suárez

      Affiliations

    • Servicio de Medicina Interna. Hospital de la Princesa. Madrid, Spain
  • ,
  • Jesús Toril

      Affiliations

    • Servicio de Medicina Interna. Centro Médico y de Rehabilitación. Barcelona, Spain
  • ,
  • Carmen Sanclemente

      Affiliations

    • Servicio de Medicina Interna. Hospital General de Vic, Spain
  • ,
  • the FRENA Investigators

      Affiliations

    • A full list of FRENA investigators is given in the Appendix.

Received 12 March 2007; received in revised form 4 July 2007; accepted 26 September 2007. published online 02 November 2007.

Abstract 

Background

The risk of future cardiovascular events in patients with peripheral artery disease (PAD) is often underestimated.

Patients and methods

FRENA is an ongoing, observational registry of consecutive outpatients with symptomatic PAD, coronary artery disease (CAD) or cerebrovascular disease (CVD). We compared the incidence of major cardiovascular events (i.e., myocardial infarction, ischemic stroke, critical limb ischemia, or cardiovascular death) during a 12-month follow-up period in a series of consecutive outpatients with PAD, CAD or CVD.

Results

As of December 2006, 1265 patients had been enrolled in FRENA who completed the 12-month follow-up. Of these, 417 patients (33%) had PAD, 474 (37%) had CAD, 374 (30%) had CVD. Patients with PAD had an increased incidence of major cardiovascular events per 100 patient-years: 17 (95% CI: 13–22) vs. 7.9 (5.5–11) in those with CAD, or 8.9 (6.1–13) in those with CVD. Compared to patients with CAD or CVD those with PAD had a similar incidence of myocardial infarction or stroke, but a higher incidence of critical limb ischemia, limb amputation and death. This incidence increased with the severity of the symptoms: 8.7 (95% CI: 5.3–13) in patients in Fontaine stage IIa; 25 (95% CI: 16–38) in stage IIb; 26 (95% CI: 13–47) in stage III; 42 (95% CI: 24–67) in stage IV.

Conclusions

Our data confirm a higher incidence of major cardiovascular events for patients with PAD, as well as a correlation of these events with the severity of PAD.

Keywords: Outcome, Peripheral arterial disease, Secondary prevention

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0953-6205(07)00260-9

doi:10.1016/j.ejim.2007.09.003

European Journal of Internal Medicine
Volume 19, Issue 3 , Pages 192-197, May 2008